RESUMEN
OBJECTIVE: To establish a high performance liquid chromatography-mass spectrometry/mass spectrometry (HPLC-MS/MS) method for determination of warfarin enantiomers in human plasma. METHODS: Warfarin enantiomers were extracted with ethyl acetate. The HPLC-MS/MS method used naproxen as internal standard, with methanol : water : formic acid = 85 : 15 : 0.05 as mobile phase, at a flow rate of 0.18 mL/min. R-warfain, S-warfarin and internal standard (IS) were separated on column MS Chiral MS-OD (50 x 2.1 mm, 3 µm). Warfarin enantiomers were protonated with electroapry ionization (ESI) in negative electron ionization mode. The ion pairs being detected were (m/z) 307.2-160.9 (R-warfain and S-warafrin) and (m/z) 228.9 --> 185.1 (IS). RESULTS: The within-run precision relative standard deviations (RSD) and between-run precision RSD of R-warfarin were 3.2%-5.8% and 2.5%-5.1%, respectively. The method recoveries and extraction recoveries of R-warfarin were (96.1 ± 5. 6)%-(105.4 ± 4.7)% and 80.7%-84.4%, respectively. The matrix effect RSD was less than 10%. The within-run precision RSD and between-run precision RSD of S-warfarin were 3.7%-5.2% and 3.2%-4.8%, respectively. The method recoveries and extraction recoveries of 5-warfarin were (98.3 ± 5.1)%-(103.7 ± 3.8)% and 81.3%-84.6%, respectively. The limit of quantification was 0.1 µg/mL for both analytes. CONCLUSION: This new method is fully validated with satisfactory accuracy and adequate reproducibility. Therefore, it can be applied for separating and detecting plasma warfarin enantiomers.
